Business Wire

Boost.ai Named as a Challenger in 2023 Gartner® Magic Quadrant™ for Enterprise Conversational AI Platforms

9.3.2023 19:01:00 EET | Business Wire | Press release

Share

Boost.ai, a leading conversational AI platform, today announced it has been recognized as a Challenger by Gartner in their 2023 Magic Quadrant for Enterprise Conversational AI Platforms. For the second consecutive year, Boost.ai has been recognized in this Magic Quadrant by Gartner for its Ability to Execute and Completeness of Vision. We believe being recognized as a Challenger reinforces the company’s strength and leadership within the conversational AI space, as it continues to expand its technology and support a growing roster of clients across the globe.

The report states that “Gartner defines the enterprise conversational AI platform market as the market for software platforms used to build, orchestrate, and maintain multiple use cases of modalities of conversational automation.” As expectations for quality customer service continue to rise globally, Boost.ai has refined its technology, deploying industry-leading virtual agents that scale to meet the requirements of enterprise organizations. Boost.ai’s solution is powered by conversational AI, and the platform allows customers to scale up individually to thousands of industry-specific intents, enabling these businesses to effectively manage a very broad scope of customer queries in a matter of weeks in virtually any industry. With consistent 90% resolution rates, the solution facilitates immediate responses with accuracy, while its no-code conversation builder and AI trainer program allow customers to self-service their virtual agents and easily deploy service flows in response to customer feedback.

“Customer experience and digital transformation continue to be a priority, and I’m proud to say we have executed on this priority at Boost.ai. Over the last year, we’ve set customers up for success with our easily adaptable and scalable technology, and have solidified ourselves as world leaders in delivering the best possible customer experience for clients,” said Jerry Haywood, CEO of Boost.ai. “From my perspective, our placement in the 2023 Gartner Magic Quadrant is a testament to the work our team has done to perfect our solution and expand our existing offers based on new trends and technology.”

We believe this latest Magic Quadrant report encapsulates a strong previous year for Boost.ai, in which the company announced multiple customer wins and partnerships in the US and UK including Aspire Insurance, Metrobank, CallMiner, and Clarasys. The company also appointed Jerry Haywood as the new CEO, bringing 20 years of enterprise technology experience. With a conversational AI platform that delivers unlimited scalability as its central offering, Boost.ai is now leveraging its technology to tackle a new AI frontier: large language models (LLMs). Boost.ai combines the generative capabilities of LLMs like GPT-3, with company data to optimize their virtual agents for improved accuracy and brand alignment. As these models continue to develop, Boost.ai is working to ensure the technology can be properly integrated to offer the most advanced enterprise solution possible for both chat and voice.

"It’s an exciting time to be in the conversational AI space as the technology has taken another leap forward with the recent advancement of powerful LLMs. We think Future Gartner Magic Quadrant reports in this category could very well be defined by how well providers respond to this trend. We’re confident that we’re integrating the tech in a way that increases efficiency and performance, but most importantly is brand safe for our customers," said Lars Ropeid Selsås, Founder of Boost.ai. “I'm excited to see the massive amount of improvement our team and solution made in just one year, and now we can set our sights on solidifying our position in the market even further."

Boost.ai continues its upward global trajectory within the Enterprise Conversational AI market. The Boost.ai platform will focus on continuing to innovate and stay at the forefront of helping enterprise organizations to deliver exceptional customer experiences.

To learn more about how Boost.ai is empowering customers like DNB and Aspire Insurance using conversational AI, please visit: https://www.boost.ai/.

Gartner Disclaimer:

GARTNER is a registered trademark and service mark of Gartner Inc. and/or its affiliates in the U.S. and internationally, and MAGIC QUADRANT is a registered trademark of Gartner, Inc. and/or its affiliates and is used herein with permission. All rights reserved.

Gartner does not endorse any vendor, product or service depicted in our research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Jon Burch
Boost.ai@resonancecrowd.com
+44 208 819 3170

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces FDA Approval of Jakafi XR™ (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease2.5.2026 00:28:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi XR™ (ruxolitinib) extended-release tablets for the treatment of adults with intermediate- or high-risk myelofibrosis (MF); adults with polycythemia vera (PV) who have had an inadequate response to or are intolerant of hydroxyurea; as well as adults and children aged 12 years and older with steroid-refractory acute graft-versus-host disease (GVHD) or chronic GVHD after failure of one or two lines of systemic therapy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260501334677/en/ “The approval of Jakafi XR reinforces Incyte’s leadership in hematology and our focus on meeting the evolving needs of patients with myeloproliferative neoplasms (MPNs) and GVHD,” said Bill Meury, Chief Executive Officer, Incyte. “Jakafi XR offers appropriate patients and physicians a once-daily option, expanding choice without changing the well-

Barilla Hosts Surprise Formula 1® Family Reunion Dinner During Miami Race Weekend1.5.2026 19:08:00 EEST | Press release

A special invitation, a table, and a plate of pasta shared by people who are often apart. That’s all it took for Barilla to bring the spirit of togetherness to Miami during the opening day of the FORMULA 1® CRYPTO.COM MIAMI GRAND PRIX 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430832316/en/ Barilla hosts Arvid Lindblad, Mikaela Shiffrin, and Nico Rosberg with Chef Massimo Bottura at Torno Subito, where the Formula 1® community came together for a surprise dinner. Barilla, the Official Pasta Partner of Formula 1®, welcomed team members and their families to Torno Subito Miami, the restaurant by three-Michelin-starred Chef Massimo Bottura, with the kitchen led by Chef Bernardo Paladini, for an evening where engines were switched off and everyday life took center stage. The night also celebrated the start of the new partnership between Barilla and the Visa Cash App Racing Bulls (VCARB) Formula 1® Team, a meeting of

TIME Names Xenco Medical one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health1.5.2026 13:07:00 EEST | Press release

Time Magazine has named pioneering medical technology company Xenco Medical as one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health. Widely regarded as the most prestigious recognition in business and technology, being selected to the TIME100 List remains the most coveted accolade that a company can achieve globally. The TIME100 Impact Awards are given to only 5 recipients each year, making it the rarest of honors that a company can receive and a profound recognition of transformative, global impact. Xenco Medical was honored by Time as the sole recipient of the TIME100 Impact Award in Health in 2026, signifying its leading, global distinction in impact on healthcare. According to Time Magazine, the TIME100 Most Influential Companies list highlights “companies making an extraordinary impact around the world.” The honor bestowed by Time comes after Xenco Medical was named the 2025 Medical Device/ Diagnostics Company of the

Inspirit Capital Completes Acquisition of Kaplan Languages Group1.5.2026 02:17:00 EEST | Press release

Inspirit Capital, a specialist investor in corporate carve-outs, and Kaplan, the global education company, have announced the completion of Inspirit’s acquisition of Kaplan Languages Group (KLG) from Kaplan. Financial terms are not being disclosed. KLG, a leading global language education platform, comprises Kaplan International Languages, Alpadia Language Schools, Azurlingua, and ESL Education. Inspirit Capital will support KLG in delivering on its ambitious growth plans, whilst continuing its fundamental mission to transform lives through language education. The next phase of ownership will see the development and launch of a refreshed standalone brand identity for KLG, with further announcements to follow on this in due course. KLG will continue to use the Kaplan name under a transitional license from Kaplan, Inc. until a new brand is announced. About Kaplan Languages Group Since 2006, KLG has provided the highest quality language education and cultural immersion experiences. Kaplan

Grindr Nominates Three New Directors to Its Board of Directors1.5.2026 00:16:00 EEST | Press release

Grindr Inc. (NYSE: GRND), the Global Gayborhood in Your Pocket™, today announced the nomination of Rob Solomon, Lisa Gersh, and Fadi Hanna to stand for election to its Board of Directors at the Annual Meeting of Shareholders on June 2, 2026. Rob Solomon is a deeply seasoned technology CEO and operator in consumer internet and marketplaces. He has held CEO and COO roles at scaled platforms including GoFundMe, Groupon, and Kayak-predecessor SideStep, and is currently CEO of leading electric aviation company H55. Lisa Gersh is a CEO and long-tenured public company director with deep experience across consumer brands, media, and commerce. She has served on the Hasbro (NASDAQ: HAS) board since 2010 and has led businesses including Oxygen Media, GOOP, and Alexander Wang. Fadi Hanna is Chief Risk Officer at Bloomberg L.P., overseeing enterprise risk across the organization. He previously worked at J.P. Morgan and has served on the board of Immigration Equality. “Over the last few years, we bu

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye